25-Mar-2026
No headlines found.
Globe Newswire (Wed, 18-Mar 9:00 AM ET)
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results
Globe Newswire (Wed, 11-Mar 4:05 PM ET)
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference
Globe Newswire (Mon, 23-Feb 8:00 AM ET)
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Pliant Therapeutics trades on the NASDAQ stock market under the symbol PLRX.
As of March 25, 2026, PLRX stock price climbed to $1.31 with 289,797 million shares trading.
PLRX has a beta of 0.90, meaning it tends to be less sensitive to market movements. PLRX has a correlation of 0.05 to the broad based SPY ETF.
PLRX has a market cap of $81.11 million. This is considered a Micro Cap stock.
Last quarter Pliant Therapeutics reported $0 in Revenue and -$.38 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.02.
In the last 3 years, PLRX traded as high as $30.85 and as low as $1.09.
The top ETF exchange traded funds that PLRX belongs to (by Net Assets): VTI, VXF, IWC, VHT, PRFZ.
PLRX has underperformed the market in the last year with a return of -12.1%, while SPY returned +15.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PLRX shares. However, PLRX has outperformed the market in the last 3 month and 2 week periods, returning +6.5% and -1.5%, while SPY returned -4.6% and -2.6%, respectively. This indicates PLRX has been having a stronger performance recently.
PLRX support price is $1.24 and resistance is $1.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLRX shares will trade within this expected range on the day.
